Gleb Denissov

1.0k total citations
9 papers, 178 citations indexed

About

Gleb Denissov is a scholar working on Toxicology, Health Information Management and Epidemiology. According to data from OpenAlex, Gleb Denissov has authored 9 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Toxicology, 2 papers in Health Information Management and 2 papers in Epidemiology. Recurrent topics in Gleb Denissov's work include Forensic Toxicology and Drug Analysis (3 papers), Autopsy Techniques and Outcomes (2 papers) and Opioid Use Disorder Treatment (2 papers). Gleb Denissov is often cited by papers focused on Forensic Toxicology and Drug Analysis (3 papers), Autopsy Techniques and Outcomes (2 papers) and Opioid Use Disorder Treatment (2 papers). Gleb Denissov collaborates with scholars based in Estonia, Russia and Belarus. Gleb Denissov's co-authors include Isabelle Giraudon, Paul Griffiths, Jane Mounteney, Marika Väli, Keiu Paapsi, Anneli Uusküla, Р. Г. Оганов, Don C. Des Jarlais, Katri Abel‐Ollo and Ilkka Vohlonen and has published in prestigious journals such as European Journal of Public Health, Scandinavian Journal of Public Health and International Journal of Drug Policy.

In The Last Decade

Gleb Denissov

8 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gleb Denissov Estonia 5 102 99 42 39 28 9 178
Alexander Olson United States 6 63 0.6× 76 0.8× 10 0.2× 37 0.9× 16 0.6× 7 142
Matthew K. Griswold United States 7 67 0.7× 93 0.9× 15 0.4× 34 0.9× 13 0.5× 11 188
Clémence Lacroix France 11 88 0.9× 31 0.3× 34 0.8× 13 0.3× 36 1.3× 28 312
Cassandra M. Pickens United States 8 18 0.2× 127 1.3× 64 1.5× 64 1.6× 22 0.8× 15 213
Leah J. Leisch United States 4 92 0.9× 52 0.5× 41 1.0× 42 1.1× 10 0.4× 4 177
Alexandra Amaducci United States 7 31 0.3× 63 0.6× 12 0.3× 36 0.9× 27 1.0× 30 158
Fridtjof Heyerdahl Norway 8 37 0.4× 64 0.6× 25 0.6× 137 3.5× 18 0.6× 33 203
Davide Radaelli Italy 9 40 0.4× 9 0.1× 18 0.4× 35 0.9× 3 0.1× 27 226
Catherine Kelly United Kingdom 9 12 0.1× 12 0.1× 15 0.4× 117 3.0× 13 0.5× 15 261
Daniela Caprara Canada 9 29 0.3× 69 0.7× 12 0.3× 11 0.3× 2 0.1× 14 311

Countries citing papers authored by Gleb Denissov

Since Specialization
Citations

This map shows the geographic impact of Gleb Denissov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gleb Denissov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gleb Denissov more than expected).

Fields of papers citing papers by Gleb Denissov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gleb Denissov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gleb Denissov. The network helps show where Gleb Denissov may publish in the future.

Co-authorship network of co-authors of Gleb Denissov

This figure shows the co-authorship network connecting the top 25 collaborators of Gleb Denissov. A scholar is included among the top collaborators of Gleb Denissov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gleb Denissov. Gleb Denissov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Abel‐Ollo, Katri, et al.. (2025). The nitazene epidemic in Estonia: a first report. European Journal of Public Health. 35(6). 1233–1240.
2.
Innos, Kaire, et al.. (2022). Evidence of overestimating prostate cancer mortality in Estonia: a population-based study. Scandinavian Journal of Urology. 56(5-6). 359–364. 5 indexed citations
3.
Jousilahti, Pekka, Р. Г. Оганов, Gleb Denissov, et al.. (2019). Preventable premature deaths (PYLL) in Northern Dimension partnership countries 2003–13. European Journal of Public Health. 29(4). 626–630. 5 indexed citations
4.
Denissov, Gleb. (2016). Sharp decrease in observed cerebrovascular mortality may be due to certification and coding. Scandinavian Journal of Public Health. 44(4). 335–337. 5 indexed citations
5.
Mounteney, Jane, Isabelle Giraudon, Gleb Denissov, & Paul Griffiths. (2015). Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. International Journal of Drug Policy. 26(7). 626–631. 128 indexed citations
6.
Denissov, Gleb, et al.. (2012). Fatal poisoning in Estonia 2000–2009. Trends in illegal drug-related deaths. Journal of Forensic and Legal Medicine. 20(1). 51–56. 32 indexed citations
7.
Denissov, Gleb, et al.. (2012). The impact of changing classifications on official fatal poisoning figures. Romanian Journal of Legal Medicine. 20(3). 197–202. 1 indexed citations
8.
Talu, Ave, et al.. (2003). Institute of Experimental and Clinical Medicine Estonian Drug Monitoring Centre Estonian National Focal Point ESTONIA DRUG SITUATION 2002. 1 indexed citations
9.
Talu, Ave, et al.. (2003). REPORT TO THE EMCDDA by the Reitox National Focal Point ESTONIA DRUG SITUATION 2003. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026